2024 annual financial data
ANI Pharmaceuticals 2024 Operating margin
Direct answer
Operating margin was 0.1%.
Operating income was 584,000 USD and net income was -18,522,000 USD.
Operating cash flow was 64,017,000 USD.
Get free ANI Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 614,376,000 USD
- Operating income
- 584,000 USD
- Net income
- -18,522,000 USD
- Operating cash flow
- 64,017,000 USD